Oulman Roxanne 4

What Happened

• Roxanne Oulman, a director of Klaviyo, was awarded 14,822 restricted stock units (RSUs) on June 9, 2026 (grant recorded at $0). On June 11, 2026 she converted 8,169 shares of Series B common stock into 8,169 shares of Series A common stock (the filing shows the derivative security disposed at $0 due to conversion). No cash changed hands in these entries.

Key Details

• Transactions and prices:
  • 2026-06-09: Award of 14,822 RSUs (listed at $0).
  • 2026-06-11: Conversion of 8,169 Series B shares into 8,169 Series A shares (conversion recorded as acquisition of Series A and disposition of the derivative at $0 / N/A value).
• Shares held after transactions (per filing): 22,521 shares of Series A Common Stock and 14,822 unvested RSUs.
• RSU vesting: RSUs vest in full on the earlier of June 9, 2027 or the issuer’s next annual meeting, subject to continued board service.
• Series B conversion terms: Series B shares are convertible into Series A at the holder’s option and may automatically convert on certain events (no expiration date).
• Other holdings/notes: Filing references 46,666 Series B shares previously transferred to the Roxanne Oulman 2025 GRAT; the reporting person disclaims beneficial ownership of those shares except to the extent of any pecuniary interest.
• Filing timeliness: Report filed June 11, 2026 covering transactions on June 9 and June 11 — no late filing indicated.

Context

• These entries are an award (RSUs) and a conversion of a convertible class of stock into common shares, not open‑market buys or sales. The RSUs are contingent and subject to vesting; the Series B conversion is a restructuring of security form rather than a sale for cash. Such conversions and awards are standard insider equity activities and do not by themselves indicate a trading view.